Posted on 11/10/20
Why Smith & Wesson, Vista Outdoor, and Sturm, Ruger Stocks All Crashed Despite Today's Vaccine News
What happenedPfizer this morning announced that its new coronavirus vaccine is 90% effective at preventing COVID-19. Is this good news?For most stocks, yes. The Dow Jones . . .
Posted on 11/10/20
Catalyst Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
CORAL GABLES, Fla., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people . . .
Posted on 11/10/20
Voyager Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR) today reported its third quarter 2020 financial results, program progress and corporate updates.“During . . .
Posted on 11/10/20
Cara Therapeutics Reports Third Quarter 2020 Financial Results
STAMFORD, Conn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to . . .
Posted on 11/10/20
Novavax Reports Third Quarter 2020 Financial and Operational Results
GAITHERSBURG, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its . . .
Posted on 11/10/20
Homology Medicines Reports Third Quarter 2020 Financial Results and Recent Highlights
BEDFORD, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today financial results for the third quarter ended . . .
Posted on 11/10/20
Abeona Therapeutics Reports Third Quarter Financial Results
NEW YORK and CLEVELAND, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced financial . . .
Posted on 11/10/20
Altimmune Announces Third Quarter 2020 Financial Results and Provides a Business Update
GAITHERSBURG, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced financial results for the three and nine months . . .
Posted on 11/10/20
TG Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the third quarter ended September 30, 2020 . . .
Posted on 11/10/20
Fortress Biotech Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO), an innovative revenue-generating company focused on acquiring, developing and commercializing or monetizing promising . . .
Posted on 11/10/20
Voyager Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR) today reported its third quarter 2020 financial results, program progress and corporate updates.“During . . .
Posted on 11/10/20
Marinus Pharmaceuticals Provides Business Update
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today provided an update . . .
Posted on 11/10/20
HealthComp Announces Partnership with New Mountain Capital
FRESNO, Calif. & NEW YORK--(BUSINESS WIRE)--HealthComp Holding Company LLC (“HealthComp” or “the Company”), a leading independent Third Party Administrator (TPA) of healthcare benefits for self-funded employers, . . .
Posted on 11/10/20
Bristol Myers Squibb Prices $7B of Senior Unsecured Notes
NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) today announced that it has priced a public offering (the “Offering”) of senior unsecured notes in a combined aggregate principal . . .
Posted on 11/9/20
Sheppard Pratt Awarded $250,000 Grant from SunTrust Charitable Irrevocable Trust
Sheppard Pratt was awarded a $250,000 grant from the SunTrust Charitable Irrevocable Trust to pilot a workforce development project to help support jobs and promote financial . . .
Posted on 11/9/20
Ambrx Closes $200M in Crossover Financing
Ambrx Inc., a clinical-stage biopharmaceutical company focused on developing Precision Biologics using an expanded
Posted on 11/9/20
Biohaven Reports Third Quarter 2020 Financial Results
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today reported financial . . .
Posted on 11/9/20
Precigen Reports Third Quarter 2020 and Year-to-Date Financial Results
Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced third . . .
Posted on 11/9/20
UroGen Pharma Reports Third Quarter 2020 Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced . . .
Posted on 11/9/20
Krystal Biotech Reports Third Quarter 2020 Financial Results
PITTSBURGH--(BUSINESS WIRE)--Krystal Biotech, Inc. (Nasdaq:KRYS), a fully integrated gene therapy company driven by its proprietary, engineered herpes simplex virus type 1 vector (HSV-1) platform, today reported . . .
Posted on 11/9/20
Scholar Rock Reports Third Quarter 2020 Financial Results and Highlights Business Progress
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, . . .
Posted on 11/9/20
Sesen Bio Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported operating results . . .
Posted on 11/9/20
Seres Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc., (Nasdaq: MCRB) today reported financial results from the third quarter ended September 30, 2020, and provided business updates.“Supported by our positive, . . .
Posted on 11/9/20
Amid National Spike, Olszewski Provides COVID-19 Update
Amid a national COVID-19 surge, Baltimore County Executive Johnny Olszewski today provided an update on the County’s ongoing response to the pandemic, announced new support for . . .
Posted on 11/9/20
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
GAITHERSBURG, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Novavax (NVAX), Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced . . .

